|
|
Management van diabetes & ACS-Cardiovasculair perspectief
|
|
|
|
Diabetes is……….
|
|
|
|
role of the A1C assay in the diagnosis of diabetes
|
|
|
|
Diabetes Risk for Early MI Mortality
|
|
|
|
Hyperglycaemia
|
|
|
|
Adverse Cardiometabolic Effects of Visceral Adipocytes
|
|
|
|
Natuurlijk beloop van type 2 Diabetes
|
|
|
|
Insulin Resistance
|
|
|
|
T2DM Exacerbates Vascular Wall Disease
|
|
|
|
Chronic Diabetes Consequences
|
|
|
|
Intensive Glycemic Control and CVD Outcomes
|
|
|
|
Early vs Late Glycaemic Intervention
|
|
|
|
Mortality in ACS : Diabetes vs no Diabetes
|
|
|
|
Impact of Revascularization: Euro-Heart Survey
|
|
|
|
SYNTAX
|
|
|
|
choice of revascularization strategy in diabetic patients.
|
|
|
|
|
PLATO diabetes
|
|
|
|
Primary endpoint
|
|
|
|
Diabetes
|
|
|
|
Reduction in risk (%)
|
|
|
|
diabetes mellitus as independent predictor of drug-eluting stent thrombosis.
|
|
|
|
Hyperglycaemie & mortaliteit bij AMI
|
|
|
|
Major Trials of GIK in AMI
|
|
|
|
Glycemia Focus Strategy
|
|
|
|
PROVE-IT
|
|
|
|
Relationship between LDL-C and CV Event Rate
|
|
|
|
Major Vascular Events
|
|
|
|
Risk of Coronary Death or Myocardial Infarction
|
|
|
|
Recommendations for Treatment Targets for LDL-C
|
|
|
|
the STENO-2 Study – 13 Years of Follow-up
|
|
|
|
STENO-2
|
|
|
|
Ten important recommendations
|
|
|
|
Ten important recommendations
|
|
Deel deze pagina met collega's en vrienden: